Linking lifestyle factors to cardiovascular risk through metabolomics: Insights from a large population of diabetic patients followed-up for 11 years.
作者信息
Tesorio Tullio, Mone Pasquale, de Donato Antonio, Trimarco Valentina, Santulli Gaetano
机构信息
Casa di Cura "Montevergine", Mercogliano (Avellino), Italy.
Department of Medicine - Wilf Family Cardiovascular Research Center, Institute for Aging Research, Fleischer Institute for Diabetes and Metabolism (FIDAM), Institute for Neuroimmunology and Inflammation (INI), Albert Einstein College of Medicine, New York City, NY, USA; University of Campania "Luigi Vanvitelli", Naples, Italy.
出版信息
Atherosclerosis. 2023 Feb;367:37-39. doi: 10.1016/j.atherosclerosis.2023.01.012. Epub 2023 Jan 21.
Abstract
摘要
相似文献
1
Linking lifestyle factors to cardiovascular risk through metabolomics: Insights from a large population of diabetic patients followed-up for 11 years.通过代谢组学将生活方式因素与心血管风险联系起来：对大量糖尿病患者进行11年随访的见解。
Atherosclerosis. 2023 Feb;367:37-39. doi: 10.1016/j.atherosclerosis.2023.01.012. Epub 2023 Jan 21.
2
Healthy lifestyle, plasma metabolites, and risk of cardiovascular disease among individuals with diabetes.健康生活方式、血浆代谢物与糖尿病患者心血管疾病风险。
Atherosclerosis. 2023 Feb;367:48-55. doi: 10.1016/j.atherosclerosis.2022.12.008. Epub 2022 Dec 26.
3
Combining serum metabolomic profiles with traditional risk factors improves 10-year cardiovascular risk prediction in people with type 2 diabetes.血清代谢组学特征与传统危险因素相结合可改善 2 型糖尿病患者的 10 年心血管风险预测。
Eur J Prev Cardiol. 2023 Sep 6;30(12):1255-1262. doi: 10.1093/eurjpc/zwad160.
4
Is predicting the risk of incident diabetes useful in patients with cardiovascular disease?预测心血管疾病患者发生糖尿病的风险是否有用？
Eur J Prev Cardiol. 2024 Oct 10;31(14):1679-1680. doi: 10.1093/eurjpc/zwae151.
5
Chronic Diseases and Lifestyle Biomarkers Identification by Metabolomics.基于代谢组学的慢性病与生活方式生物标志物识别
Adv Exp Med Biol. 2017;965:235-263. doi: 10.1007/978-3-319-47656-8_10.
6
Cardiovascular risk of chronic coronary syndrome patients according to vascular phenotype, diabetes, and smoking.根据血管表型、糖尿病和吸烟情况分析慢性冠状动脉综合征患者的心血管风险
Eur J Prev Cardiol. 2022 Feb 19;29(1):e35-e37. doi: 10.1093/eurjpc/zwaa137.
7
[Schizophrenia increases risk of diabetes and cardiovascular diseases].精神分裂症会增加患糖尿病和心血管疾病的风险。
Duodecim. 2005;121(7):705-7.
8
Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease: a meta-analysis.糖尿病合并非酒精性脂肪性肝病患者心血管风险的协同增加：一项荟萃分析。
Eur J Gastroenterol Hepatol. 2018 Jun;30(6):631-636. doi: 10.1097/MEG.0000000000001075.
9
Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts.代谢物谱分析与心血管事件风险：基于人群的3个队列的前瞻性研究
Circulation. 2015 Mar 3;131(9):774-85. doi: 10.1161/CIRCULATIONAHA.114.013116. Epub 2015 Jan 8.
10
Omega-3 polyunsaturated fatty acids supplementation in patients with diabetes and cardiovascular disease risk: does dose really matter?ω-3 多不饱和脂肪酸补充剂在糖尿病和心血管疾病风险患者中的应用：剂量真的重要吗？
Cardiovasc Diabetol. 2018 Aug 28;17(1):119. doi: 10.1186/s12933-018-0766-0.
引用本文的文献
1
The potential preventive effect of probiotics, prebiotics, and synbiotics on cardiovascular risk factors through modulation of gut microbiota: A review.益生菌、益生元及合生元通过调节肠道微生物群对心血管危险因素的潜在预防作用：一项综述
Food Sci Nutr. 2024 May 29;12(7):4569-4580. doi: 10.1002/fsn3.4142. eCollection 2024 Jul.
本文引用的文献
1
Healthy lifestyle, plasma metabolites, and risk of cardiovascular disease among individuals with diabetes.健康生活方式、血浆代谢物与糖尿病患者心血管疾病风险。
Atherosclerosis. 2023 Feb;367:48-55. doi: 10.1016/j.atherosclerosis.2022.12.008. Epub 2022 Dec 26.
2
Association between NMR metabolomic signatures of healthy lifestyle and incident coronary artery disease.健康生活方式的 NMR 代谢组学特征与冠心病事件的相关性。
Eur J Prev Cardiol. 2023 Feb 14;30(3):243-253. doi: 10.1093/eurjpc/zwac252.
3
Metabolomics: Going Deeper, Going Broader, Going Further.代谢组学：深入、广泛、持续发展。
Methods Mol Biol. 2023;2554:155-178. doi: 10.1007/978-1-0716-2624-5_11.
4
The metabolomic profile associated with clustering of cardiovascular risk factors-A multi-sample evaluation.与心血管危险因素聚类相关的代谢组学特征——多样本评估。
PLoS One. 2022 Sep 15;17(9):e0274701. doi: 10.1371/journal.pone.0274701. eCollection 2022.
5
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles.非酒精性脂肪性肝病患者的代谢亚型表现出独特的心血管风险特征。
Hepatology. 2022 Oct;76(4):1121-1134. doi: 10.1002/hep.32427. Epub 2022 Mar 17.
6
Innovative Approaches to Assess Intermediate Cardiovascular Risk Subjects: A Review From Clinical to Metabolomics Strategies.评估心血管疾病中危风险受试者的创新方法：从临床到代谢组学策略的综述
Front Cardiovasc Med. 2021 Dec 22;8:788062. doi: 10.3389/fcvm.2021.788062. eCollection 2021.
7
Non-targeted metabolomics identify polyamine metabolite acisoga as novel biomarker for reduced left ventricular function.非靶向代谢组学鉴定多胺代谢物 acisoga 为左心室功能降低的新型生物标志物。
ESC Heart Fail. 2022 Feb;9(1):564-573. doi: 10.1002/ehf2.13713. Epub 2021 Nov 22.
8
Metabolic profiling links cardiovascular risk and vascular end organ damage.代谢组学将心血管风险与血管终末器官损伤联系起来。
Atherosclerosis. 2021 Aug;331:45-53. doi: 10.1016/j.atherosclerosis.2021.07.005. Epub 2021 Jul 13.
9
Cis-epistasis at the LPA locus and risk of cardiovascular diseases.LPA 基因座的顺式上位性与心血管疾病风险。
Cardiovasc Res. 2022 Mar 16;118(4):1088-1102. doi: 10.1093/cvr/cvab136.
10
Systems biology in cardiovascular disease: a multiomics approach.心血管疾病中的系统生物学：一种多组学方法。
Nat Rev Cardiol. 2021 May;18(5):313-330. doi: 10.1038/s41569-020-00477-1. Epub 2020 Dec 18.
Zotero 插件